Download this White Paper
Decentralized Clinical Trials (DCTs) include collecting data through sensors or remote monitoring devices carried by a patient without the need to visit a sit. These trials can deliver many benefits to pharmaceutical companies, including cost savings and improved data quality. DCT platform providers are taking an ecosystem approach to address challenges in the DCT space through various partnerships and M&As. Through co-innovation, continuous product improvement, and market education, DCT platform providers are focusing on increasing trust, speeding up trial timelines, and delivering a smooth experience in running DCTs.
This report assesses the capabilities of 24 platform providers specific to the decentralized clinical trial platform. These platform providers are mapped on the Everest Group PEAK Matrix, which is a composite index of a ran of distinct metrics related to a providers' capability and market impact. Download now to learn about:
The landscape of platform providers for DCTs
Assessment of the DCT platform providers on several capability and market success-related dimensions
Offered Free by: Medable
See All Resources from: Medable